347850 - D & D Pharmatech, Inc.

347850 Summary
Biopharma
Stock Price & Overview
₩49,300 -400 (-0.80%) Close · Sep 8, 2026 KST
KOSDAQ | ₩KRW | Close: ₩49,300  ≈ US$35  ·  Market cap ₩2.3tn (≈ $1.6bn)

Insider / Major Shareholder Holdings Report ×2

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 임원ㆍ주요주주특정증권등소유상황보고서

347850

Price
₩49,300
Change
-0.80%
Market cap
₩2.3tn
Prev. close
₩49,700
347850 SummaryCompare to Peers

347850 data on kstock

Financials
11 fiscal years

Every figure is taken from D & D Pharmatech, Inc.'s own DART filings and matched on IFRS account codes, so a line holds across years where the Korean wording changed.

More 347850 filings

Material matter affecting investment judgment (clinical trial result)

08/21/26

Half-Year Report

08/14/26

Single Supply Contract Signed

07/14/26

Conversion rights exercised

06/22/26

Repurchase of its own convertible bonds before maturity

06/15/26

5% Ownership Report — Large Holdings

06/11/26
All 347850 filings